Human granulocyte/macrophage colonystimulating factor (GM-CSF) is a glycoprotein that is essential for the in vitro proliferation and differentiation of precursor cells into mature granulocytes and macrophages. In this report we have used a mouse GM-CSF cDNA clone to isolate human GM-CSF clones from libraries made from HUT-102 messenger RNA and mitogen-stimulated T-lymphocyte messenger RNA. The human cDNA clones contained a single open-reading frame encoding a protein of 144 amino acids with a predicted molecular mass of 16,293 daltons and showed 69% nucleotide homology and 54% amino acid homology to mouse GM-CSF.
The gene for human GM-CSF appears to exist as a single-copy gene.
The growth and differentiation of hematopoietic cells is mediated by a number of glycoproteins, collectively known as colony-stimulating factors (CSFs), including granulocyte/ macrophage colony-stimulating factor (GM-CSF), granulocyte-CSF (G-CSF), macrophage-CSF (M-CSF), and multi-CSF (interleukin 3) (1, 2). There has been considerable difficulty in defining these regulatory proteins, partly because they have been obtained from a variety of sources and characterized by their capacity to generate hematopoietic cells of various lineages in vitro. An understanding of the biology and biochemistry of these CSFs is further complicated by their existence in small quantities. Molecular cloning and expression of these factors should lead to a better definition of their structure and biological activities and exploration of their possible therapeutic uses.
GM-CSF is a glycoprotein that is required for the production of granulocytes and macrophages from normal bone marrow and appears to regulate the activity of mature, differentiated granulocytes and macrophages (1, 3, 4) . Human GM-CSF, which has been isolated recently from the Mo T-lymphoblast cell line, has been shown to modulate the activities of mature neutrophilic granulocytes and appears to be identical to a neutrophil migration-inhibition factor from T lymphocytes (NIF-T) (5) . A murine GM-CSF cDNA clone has been obtained following the determination of a partial amino-terminal sequence for the protein purified from mouse lung-conditioned medium (6, 7) .
We report here the molecular cloning of human GM-CSF from cDNA libraries prepared from the HUT-102 cell line and from mitogen-stirnulated T lymphocytes. The human sequences were isolated by hybridization with a mouse GM-CSF cDNA probe and were shown to direct the synthesis of biologically active GM-CSF using a yeast expression system.
MATERIALS AND METHODS
Construction and Analysis of Libraries. Polyadenylylated messenger RNA was isolated from human peripheral blood T lymphocytes stimulated with concanavalin A (Con A) and phorbol myristate acetate (PMA) at 20 gg/ml and 10 ng/ml, respectively, and from the mouse T-lymphoma cell line LBRM-33-5A4 (ATCC-CRL-8080) stimulated with 1% phytohemagglutinin M (PHA-M). Procedures for RNA purification and cDNA library construction have been described (8) .
Small-scale plasmid DNA preparations from pools representing approximately 1 x 105 transformants were digested with Pst I, electrophoresed on 0.8% agarose gels, blotted onto nitrocellulose filters, and hybridized either with cDNA probes (32P-labeled by nick-translation) or with oligonucleotide probes (labeled with T4 polynucleotide kinase). Hybridizations were for 16 hr at 55°C in 6x NaCl/Cit (1 x NaCl/Cit = 0.15 M NaCl/0.015 M sodium citrate, pH 7) containing 0.1% sarcosyl, 5x Denhardt's solution (1x = 0.02% polyvinylpyrrolidone/0.02% Ficoll/0.02% bovine serum albumin), 0.5% Nonidet P-40, 100 ,ug of denatured saltron sperm DNA per ml, and probe at 106 cpm/ml. Filters were washed extensively in 6x NaCl/Cit at room temperature, and then washed for 1 hr at 42°C and for 1.5 hr at 55°C before autoradiography. Positive pools containing the largest hybridizing cDNAs were subdivided, and the process was repeated until pools of 2,000-10,000 transformants were obtained. Then these pools were used in colony filter hybridization experiments (9) to identify transformants that hybridized strongly with the probes. DNA from the cDNA clones was subcloned into M13 mpl8 and mpl9 (10) and sequenced by the chain-termination method (11) as described (12, 13) .
Expression of Human GM-CSF in Yeast. An expression vector ( Fig. 1 ) was constructed which included pBR322 sequences, the TRPI gene of yeast for tryptophan selection, the yeast 2-lim origin of replication, and the yeast a-factor promoter and leader sequences sufficient to direct the synthesis and secretion of foreign proteins (14) . The EcoRI to HindIlI a-factor fragment was obtained by cloning the a-factor gene using as a probe a synthetic oligonucleotide derived from published sequences (15) . The SfaNI-Nco I fragment of pHQ23 (see Fig. 2A ) was fused in-frame to the a-factor signal sequence by use of a synthetic oligonucleotide (Fig. 1) . This oligonucleotide linker joins the HindIII site of a factor to the SfaNI site of GM-CSF, adding a second a-factor processing site to obtain complete processing of the signal (14) for secretion of the mature form of GM-CSF.
Abbreviations: CSF, colony-stimulating factor; GM-CSF, granulocyte/macrophage CSF; Con A, concanavalin A; PMA, phorbol myristate acetate; bp, base pair(s).
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked Cultures to be assayed for biological activity were grown in 20-50 ml of rich media (1% yeast extract/2% peptone/2% glucose) at 30°C to stationary phase. The protease inhibitors phenylmethylsulfonyl fluoride and pepstatin A were added at the time of harvest to a final concentration of 1 mM and 10 ,uM, respectively. Cells were then removed by centrifugation, and the medium was filtered through a 0.45-,um cellulose acetate filter.
Preparation of Human Bone Marrow Cells. Human bone marrow from the iliac crest of healthy donors was collected in a heparinized syringe. The marrow was diluted 1:3 with phosphate-buffered saline at room temperature and layered onto a solution of 54% Percoll (Pharmacia). After centrifugation at 500 x g at room temperature for 20 min, the interface was collected and washed with 20 vol of phosphatebuffered saline. The suspension was then centrifuged at 250 x g for 10 min. Cells were resuspended in the desired volume of alpha minimal essential medium (MEM a medium) with nucleotides (GIBCO) for cell counting and viability determination. Serum was then added, and the cell suspension was stored on ice until assay.
Colony Assay. (GIBCO) . The cultures were incubated in humidified 5% C02/95% air at 37°C and examined after 7 and 14 days to determine the number and type of colonies (granulocyte, macrophage, and mixed granulocyte/macrophage).
RNA Analysis. Primer extension experiments were performed as described (8) except that electrophoresis was in a 6% polyacrylamide/8 M urea gel.
Total RNA for Northern blots was isolated by the guanidinium thiocyanate/cesium chloride method (16). Samples were then electrophoresed in 1.1% agarose gels containing formaldehyde, transferred to nitrocellulose filters (16) , and hybridized with a 32P-labeled RNA probe transcribed by SP6 polymerase (17) . The 32P-RNA probe was synthesized from the 600-base-pair (bp) Pst I to Nco I fragment ofpHG23, which was inserted into pSP64 (Promega Biotec, Madison, WI). Hybridization and washing ofblots was as described (8) .
RESULTS
Cloning and Sequencing of Mouse and Human GM-CSF DNA. A cDNA library was constructed with polyadenylylated messenger RNA from the mouse T-cell lymphoma line LBRM-33-5A4 stimulated with phytohemagglutinin. An oligonucleotide complementary to the 40 nucleotides at the 5' end of the published sequence for mouse GM-CSF (6) was synthesized, labeled with 32p, and used as a hybridization probe to screen the library. One hybridizing clone, TH1, was isolated and sequenced (Fig. 2B) . This sequence contained a single, long, open-reading frame beginning 27 nucleotides 5' of the previously published sequence for mouse GM-CSF and largely identical to it except for a few nucleotide changes. The two sequences will be compared elsewhere (unpublished data). The cDNA ofTH1 has been shown to direct production of biologically active GM-CSF using a yeast expression system (unpublished results).
A 372-bp Hae III fragment from TH1, extending from nucleotide positions 42 to 414 (Fig. 2B) was isolated, nicktranslated, and used under conditions of low stringency to probe two human cDNA libraries that were constructed from mRNA isolated from either the human cell line HUT-102 or from mitogen-stimulated human peripheral blood T lymphocytes. A number of cDNA clones that contained sequences complementary to the mouse GM-CSF probe were isolated from these libraries and shown by cross-hybridization and restriction mapping to be related. The cDNA from two of these HUT-102 clones (pHG23 and pHG25) is shown in Fig.  2A . Sequence analysis of these clones showed an openreading frame encoding a protein of 144 amino acids with a predicted molecular mass of 16,293 daltons. The cDNA includes the predicted amino acid sequence Ala-Pro-Ala-ArgSer-Pro-Ser-Pro-Ser, which is identical to the reported amino terminus for mature human GM-CSF protein (5). The 5' end of the open-reading frame encodes a region of 17 amino acids, with a potential initiator methionine and many of the characteristics expected of a hydrophobic signal peptide for a secreted protein (18) .
Synthesis of Recombinant GM-CSF in Yeast. To show that the cDNA in pHG23 encoded a protein with GM-CSF activity, we constructed a plasmid designed to direct synthesis and secretion of the mature form of GM-CSF from yeast (see Fig. 1 ). Secretion of the mature protein is expected to result in glycosylation of the protein. The construction contains the yeast a-factor promoter plus leader sequences sufficient to direct the secretion of GM-CSF, followed immediately by the sequence for mature GM-CSF beginning with the alanine at amino acid position 1 in Fig. 2B . Supernatants from yeast transformed with the GM-CSF expression plasmid or from the control plasmid, pYaf, lacking the GM-CSF sequences of Fig. 1 3' untranslated regions are not shown. The nucleotides are numbered from the presumed initiator methionine codon in the human GM-CSF and from the first nucleotide in the mouse GM-CSF. The amino acids are numbered from the amino terminus of the mature proteins, the alanine residues marked with a star. Boxed amino acid residues indicate regions of homology between the mouse and human proteins. Triangles represent possible N-linked glycosylation sites.
as the control plasmid, pYaf, produced supernatants with no activity. The titer [granulocytic progenitor cells (CFU-C) per ml] was calculated by multiplying by 50 the reciprocal of the dilution giving 50% of the maximum colony number: pYafGm-2, 1.25 x 106 CFU-C per ml; pYaf, 0 CFU-C per ml; placental cells, 5 x 102 CFU-C per ml. (In seven experiments with different donors, the average maximum number of colonies from 105 marrow cells was 96 ± 29.) At 14 days, the recombinant GM-CSF and placental cell supernatants each produced well-defined colonies, of which approximately one-third was granulocyte/macrophage colonies, one-third was dispersed macrophage colonies, and one-third was tight granulocyte colonies. We have observed the same types of colonies with recombinant murine GM-CSF in murine bone marrow colony assays (unpublished data).
Analysis of mRNA. Since the availability of cells that synthesize GM-CSF is limited, we investigated the expression of GM-CSF mRNA from a number ofcell types that have been reported previously to express other CSFs. Blots of RNA from these cells were analyzed by hybridization with a probe derived from pHG23. Fig. 3 Left shows strong hybridization to a band of approximately 900 nucleotides in RNA from peripheral blood T cells activated with PMA and Con A and from HUT-102 cells (lanes 3 and 1) . A low level of hybridization was seen in RNA from a human bladder tumor cell line (lane 6) and no hybridization was seen in RNA from unstimulated T cells, lipopolysaccharide-stimulated macrophages, and a human pancreatic tumor cell line (lanes 2, 4, and 5). Other, higher molecular weight bands in Fig. 3 Left are due to hybridization of the probe to ribosomal RNA.
To determine the position of the 5' end of the GM-CSF mRNA, primer extension experiments were performed by using an oligonucleotide complementary to the mRNA from nucleotide numbers 38-57 in Fig. 2B . A single primer extension product of 89 nucleotides was seen with RNA from mitogen-stimulated T cells (Fig. 3 Right), indicating that the cDNA of pHG25 is approximately 17 bp short of the 5' end of the natural mRNA. Therefore, this mRNA must have an extremely short 5' untranslated region. No primer extension product was seen with RNA from the T-cell lymphoma line Jurkat. Analysis of Genomic Sequences. To determine the number of GM-CSF-related genes in human DNA, we hybridized a 32P-labeled human GM-CSF probe to Southern blots of human DNA digested with a number of restriction enzymes expected to cut relatively infrequently. The results (Fig. 4) show that digestion with HindIII, EcoRI, or Pst I gave rise to a single band, while digestion with Bgl II gave rise to two bands. On the basis of these results, it appears probable that the gene for GM-CSF exists as a single-copy gene.
DISCUSSION
In this study we have used a murine GM-CSF cDNA probe to isolate a homologous sequence from human cDNA libraries. Two lines of evidence support the assumption that this sequence corresponds to the human GM-CSF gene. The amino acid sequence of the protein predicted from our nucleotide sequence includes nine amino acids that are identical to those reported by Gasson et al. (5) for the amino terminus of naturally occurring human GM-CSF. In addition, we have constructed an expression plasmid designed to direct the synthesis and secretion of this protein by yeast and have shown that it can stimulate the growth of granulocyte, macrophage, and granulocyte/macrophage colonies from human bone marrow.
In contrast, the secreted, recombinant human GM-CSF showed no activity in three biological assays that respond to recombinant murine GM-CSF. These are: a murine bone marrow colony assay, a murine bone marrow proliferation assay, and a murine bone marrow macrophage proliferation assay. Similarly, recombinant murine GM-CSF has shown no activity in human bone marrow assays (unpublished data). This lack of cross-species activity contrasts to that reported for human macrophage CSF, which can stimulate the growth of murine macrophages (19) .
The human GM-CSF nucleotide sequence reported here predicts a molecular mass for the mature polypeptide of 14,476 daltons, starting at the position corresponding to the published amino terminus (position 1 in Fig. 2B ). The naturally occurring glycoprotein purified from the Mo Tlymphoblast cell line is reported to have a molecular mass of 22,000 daltons (5), indicating that it could contain up to 34% carbohydrate by weight. Potential N-linked glycosylation sites exist at asparagine residues 27 and 37. Interestingly, the sequence of murine GM-CSF also contains two potential N-linked glycosylation sites, but in a different region of the molecule (asparagine residues 66 and 75). Comparison of the human and mouse sequences reveals substantial homology at both the nucleotide (69%) and amino acid (54%) levels throughout the coding regions. The amino terminus of murine GM-CSF has been reported to be Ile-7, whereas sequence comparison with human GM-CSF would suggest Ala-1 as a more likely possibility. The position of the carboxyl terminus of the two proteins is identical, as are the positions of the four cysteine residues, indicating the possible importance of disulfide bond formation in these molecules (5) . The human sequence has an insertion of nine nucleotides relative to the mouse sequence, giving rise to three additional amino acids at positions [23] [24] [25] .
The assignment of the initiator methionine at position -17 must be considered as preliminary in the absence of any upstream, in-phase, termination codons or of the full-length cDNA sequence. However, as we have sequenced to within 17 nucleotides of the 5' end of the mRNA, and the signal sequence predicted here conforms well to those reported for
